Internal Medicine, Infectious Disease · Fort Lauderdale, FL
NPI
1053374017
Since 2006
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
4800 Federal Highway, Suite 203
Fort Lauderdale, FL, 33308
Phone (954) 372-1038
Groups this clinician bills Medicare through
Medicare paid, 2024
$127K
1,661 services
Medicare patients, 2024
433
Average age 77
Drug cost, 2024
$5.3M
5,878 prescriptions
Company payments, 2025
$36.95
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Margaret J Gorensek was code 99232 (hospital e&m - subsequent), 768 times for 237 patients. In total Margaret J Gorensek billed 1,661 services in 12 codes, and Medicare paid $127K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-05-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 768 | 237 | $63.14 | $48K |
| 99223 Hospital E&M - Initial | Facility | 242 | 219 | $136.41 | $33K |
| 99231 Hospital E&M - Subsequent | Facility | 226 | 137 | $39.42 | $8,909 |
| 99214 Office E&M - Established | Office | 126 | 80 | $88.64 | $11K |
| 99233 Hospital E&M - Subsequent | Facility | 112 | 47 | $93.51 | $10K |
| 99213 Office E&M - Established | Office | 79 | 56 | $61.97 | $4,896 |
| 99222 Hospital E&M - Initial | Facility | 76 | 74 | $99.19 | $7,538 |
| 99204 Office E&M - New | Office | 13 | 13 | $126.76 | $1,648 |
By year: 2022 $157K for 2,059 services; 2023 $159K for 2,105 services; 2024 $127K for 1,661 services.
Medicare prescription drug claims, 2024
In 2024, the drug Margaret J Gorensek prescribed most often to Medicare patients was Tivicay (Dolutegravir Sodium), with 317 prescriptions and refills. In total Margaret J Gorensek wrote 5,878 Medicare prescriptions that cost $5.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tivicay Dolutegravir Sodium | 317 | 325 | 41 | $837K |
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 270 | 278 | 40 | $1.1M |
| Descovy Emtricitabine/Tenofov Alafenam | 222 | 232 | 29 | $525K |
| Isentress Raltegravir Potassium | 180 | 180 | 16 | $392K |
| Rosuvastatin Calcium Generic | 156 | 300 | 36 | $3,645 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 145 | 197 | 41 | $1,397 |
| Triumeq Abacavir/Dolutegravir/Lamivudi | 139 | 147 | 19 | $565K |
| Doxycycline Monohydrate Generic | 135 | 180 | 61 | $5,790 |
| Valacyclovir Valacyclovir Hcl | 112 | 142 | 27 | $5,973 |
| Prezcobix Darunavir/Cobicistat | 109 | 117 | 12 | $294K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 104 | 110 | 28 | $2,093 |
| Ritonavir Generic | 100 | 114 | 12 | $11K |
| Gabapentin Generic | 95 | 119 | 16 | $1,413 |
| Amlodipine Besylate Generic | 91 | 187 | 25 | $271 |
| Cephalexin Generic | 86 | 127 | 32 | $952 |
Brand drugs: - claims; generic drugs: 4,036 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Margaret J Gorensek $36.95 ($36.95 in general payments such as food, travel and fees) from 1 company. The largest payer was Gilead Sciences, Inc. with $36.95.
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. GILD | 2 | $36.95 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.